BCL2L1 and cancer: This anti-apoptotic activity contributes to cancer development and also resistance to chemotherapy, as cancer cells often control the death mechanisms by elevating the expression of BCL-2, BCL-XL, and MCL-1, which neutralises the apoptotic action of the BH3-only proteins of the BCL-2 family [106].